EvergoldLongevity’s Simone Rossignol explains

New filing expands NorthStrive Biosciences’ pu

Real-time clinical trials could accelerate drug

A genome pioneer who read life as code – and r

BioCardia announced the allowance of a Japanese p

Insilico Medicine announced that the inhalation f

Alector confirmed it will discontinue the Phase 2

Stealth provided a commercial and research update

Renibus announced that data from the Phase 3 PROT

Deal strengthens cyclodextrin IP targeting ApoE4

A new obesity approach targets fat storage pathw

Sana and Mayo Clinic partner to advance a potent

Metashape Pharma announced that new preclinical d

VectorY Therapeutics has received authorization f

Leading experts warn that ageism and outdated bu

NorthStrive Biosciences Inc.

NorthStrive Biosciences Inc.

Aesthetic Record has acquired Joya Health, a corp

The molecular biology firm joins the Tobacco Doc

The Super Age Games introduce a new competition

Munich startup dehaze targets earlier detection

Deal unites clinical diagnostic powerhouse with

Alterity Therapeutics received positive regulator

Aspen presented 12-month data from the first eigh

Voyager will present eight oral and poster presen

Annovis has published peer-reviewed Phase 2/3 res

New funding and partnerships position Endlyz to

Collaboration signals rising confidence in gene

Smart Nanovirus debuts RIGVIR X, a monthly liqui

New trial data point to longer-lasting mobility

Belgian biotech targets SIK3 to shift autoimmune

The U.S.

Alnylam has advanced its investigational RNAi can

Sana Biotechnology announced an abstract highligh

What if aging well isn’t about losing weight,

New Longevity Show blog shows why employers must

Fast Track status for 4P004 signals a push to ac

A new program offers deeper health insights and

Calluna Pharma has completed enrollment in its gl

Insilico Medicine announced the nomination of ISM

Nuritas will exhibit at Vitafoods Europe 2026, ta

A new board aims to turn aging into a treatable

New training marketplace pairs NUS rigor with Lo

Final patient visit completed as ACD856 moves cl

Next-gen tremor device brings more personalized,

Alterity presented new analyses from its ATH434-2

Rafael Holdings, Inc.

4Moving Biotech announced that the U.S.

Antag Therapeutics will present clinical and prec

Springfield Wellness Center marked its 25th anniv